Pemazyre 4.5 mg tablets clinical trials

PEARLDIFER - A Phase II study of pemigatinib after curative local therapy in locally advanced intrahepatic cholangiocarcinoma (iCCA) harboring FGFR2 fusions/rearrangements

This study looks at a new tablet treatment called Pemazyre for a specific liver cancer in people who have already had surgery or other treatments. It aims to see if the medicine can stop the cancer from coming back and how people feel while taking it.